Resverlogix Corp. | Key People and Executives
Donald J. McCaffrey
Chairman, President, CEO & Secretary
Norma K. Biln
Independent Director
Eldon R. Smith
Lead Independent Director
Shawn Lu
Independent Director
Kelly B. McNeill
Independent Director
Kenneth J. Zuerblis
Independent Director
Donald J. McCaffrey
Chairman, President, CEO & Secretary
Anthony Brad Cann
Chief Financial Officer
Norman C. W. Wong
Chief Scientific Officer
Ewelina Kulikowski
Senior Vice President-Scientific Development
Michael T. Sweeney
Senior Vice President-Clinical Development
Jan O. Johansson
Senior Vice President-Medical Affairs
Henrik C. Hansen
Vice President-Intellectual Property
Kenneth E. Lebioda
Senior VP-Business & Corporate Development
Paul Moon
VP-Investor Relations & Communications
Norma K. Biln
Independent Director
Eldon R. Smith
Lead Independent Director
Shawn Lu
Independent Director
Kelly McNeill
Independent Director
Kenneth J. Zuerblis
Independent Director
| Address |
4820 Richard Road SW
Calgary Alberta T3E 6L1
Canada
|
|
Employees
|
- |
| Website |
http://www.resverlogix.com |
| Updated |
07/08/2019 |
| Resverlogix Corp. is a clinical stage biotechnology company, which engages in the research and development of pharmaceutical products for cardiovascular diseases. It develops Apabetalone for diabetes mellitus, chronic kidney, peripheral artery, Orphan and Alzheimer's diseases. The company was founded by Donald J. |
